Bank of Montreal
CVAC

Bank of Montreal’s CureVac CVAC Stock Holding History

Bank of Montreal’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-250
Closed -$22K – 3952
2021
Q1 		$22K Buy
+250
New +$24.3K ﹤0.01% 4008

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of Montreal's CVAC Position: Q2 2021 in Review

Bank of Montreal sold out of CureVac (CVAC) in Q2 2021, closing a stake of 250 shares — an estimated $22K sold.

Bank of Montreal first reported a position in CVAC in Q1 2021 and held it in 1 quarter. The position peaked at $22K in Q1 2021. 109 funds tracked by Wall St. Rank hold CVAC as of Q2 2021.

  • Bank of Montreal reported no remaining CureVac position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 250 CureVac shares in Q2 2021, an estimated $22K.
  • Bank of Montreal first reported a position in CureVac in Q1 2021 and held it in 1 quarter.
  • Bank of Montreal's CureVac position peaked at $22K in Q1 2021.
  • 109 funds tracked by Wall St. Rank held CureVac as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.